Loading page...

Romanian Business News - ACTMedia :: Services|About us|Contact|RSS RSS

Subscribe|Login

Romania has sold 1,170,000 doses of vaccine so far

210728095115stock_vector_covid_coronavirus_vaccine_syringe_and_vaccine_vial_flat_icons_treatment_for_coronavirus_covid_1924349555.jpg

 Secretary of State with the Ministry of Health Andrei Baciu, CNCAV (Coordinating Committee for Vaccination Activities against COVID-19) vice-president, on Tuesday said that Romania has so far sold 1,170,000 doses of vaccine, donated some of the doses and has planned to donate more.

"We sold 1,170,000 doses of vaccine to Denmark, we donated over a half million doses to the Republic of Moldova, 100,800 to Ukraine, 30,000 to Argentina, and 50,4000 to Serbia. And these are only the agreements that were already finalized," Andrei Baciu told a press conference at the Victoria Palace.

He also provided clarification on vaccine doses that are close to their expiration term.

"There are 1,400,000 doses that expire at the end of August. They expire every month, actually (...) So it's a cycle, a life expectancy, so to speak, natural for all vaccines, not just for those who arrive in Romania, but for all those who are distributed at European level. Hence the importance of an efficient stock management," Baciu also stated.

The vice-president of CNCAV specified that Romania received 17,662,029 doses of vaccine until July 26, and at this moment there is a stock of 6,048,043 doses.

"Of these, most are produced by BioNTech/Pfizer - 11,595,129, Moderna - 1,705,200. We also received 3,374,000 doses of vaccine produced by AstraZeneca, and 987,800 doses of the Johnson&Johnson vaccine," said Baciu.

He said that for the next period, the authorities have estimated deliveries for July of 1,177,000 doses of vaccine.

"But we must keep in mind that we have suspended deliveries for some of the vaccines, precisely to have the most efficient management of stocks, and for August we have so far confirmed a delivery of 868,800 doses of Moderna. In fact, there will be 217,000 doses delivered weekly, while for the other vaccines produced by the other companies we are waiting for the confirmations, as a result of the suspension of deliveries for June and part of July," Baciu also showed.

 

The vaccination coverage rate at national level is currently about 30pct, almost 48pct in Bucharest, followed by Cluj County, with almost 44pct, head of CNCAV (National Committee Coordinating Vaccination Activities against COVID-19), doctor Valeriu Gheorghita, said on Tuesday.

"In terms of the vaccination coverage at national level, for the eligible population resident in Romania, according to the National Institute of Statistics, we are talking about a reference number of 19.3 million people. If we look at the eligible population over 12 years, the vaccination coverage rate is now about 30pct. Regarding the vaccination coverage in Bucharest and by counties, and considering the eligible population over 12, there are 10 counties, including the municipality of Bucharest, which have a vaccination coverage rate of over 30pct, 26 counties that have a coverage rate between 20 and 30pct, and there are six counties that have a vaccination coverage rate between 17 and 20pct. Looking at the highest rates, Bucharest is at almost 48pct vaccination coverage rate, Cluj county at almost 44pct, Sibiu, Timis, Brasov, Constanta, Alba, Ilfov, Mures, Salaj countis are between 30 and 35pct," Valeriu Gheorghita told a press conference at the Government.

He also noted that, more than 4.95 million people were vaccinated nationwide with at least one dose, by the date of July 26, with more than 95pct of them being fully vaccinated.

Regarding the profile of the side effects recorded at the national level, the head of CNCAV said a total of 16,776 cases of post-vaccine side effects were reported, with a reporting rate of 1.79 per thousand doses administered.

"For the past week reports showed 47 side effects, with a median age of 34 people reporting these side effects, which were not severe, in any of the cases, most of which were local side effects, and systemic," explained Gheorghita.

 (Photo:https://www.shutterstock.com/)

More